As mentioned in a previous report showing a higher hippocampal loss in the presence of APOE-ε4, the authors suggested that increased brain volume loss could be an indicator of Alzheimer's disease pathology and a potential marker for the efficacy of therapeutic interventions in Alzheimer's disease (36). This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.